Diabetes mellitus and risk of breast cancer: A meta‐analysis
By S. Larsson, C. Mantzoros, A. Wolk. International Journal of Cancer, 2007
842 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/53ccd85f69d4aa4c7aebeea65b3a5e7024e812ad
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Molecular Biology
- D. Iliopoulos
- Heather A. Hirsch
- Kevin Struhl
- Y. Ding
- Yoshimasa Tanaka
- Wen Zhang
- Yanling Wu
- D. Leroith
In Oncology
- Heather A. Hirsch
- Kevin Struhl
- D. Iliopoulos
- R. C. V. van Kruijsdijk
- Ali G. Moghaddam
- H. Salehiniya
- M. Woodward
- Zohre Momenimovahed
Citations in the corpus
- Obesity and Cancer: The Role of Dysfunctional Adipose Tissue (2009, background): “In addition, diabetes mellitus, a disease characterized by insulin resistance, is associated with an increased risk of breast, colorectal, pancreatic, and bladder cancer (58-61).”
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetes (2009, background): “Diabetes carries an increased risk of breast [16], colon [4] and pancreatic [17] cancer, each of which features among the top five causes of cancer mortality in the USA [2].”
- Obesity and Risk of Colorectal Cancer: A Meta-analysis of 31 Studies with 70,000 Events (2007, background): “, pancreas (59), breast (60), and bladder (61) Figure 3.”
- Epidemiological characteristics of and risk factors for breast cancer in the world (2019, background): “Findings of a meta-analysis revealed that women with diabetes (especially those with type II diabetes) are at 20% increased risk of developing breast cancer.(156) Researchers suggest that in postmenopausal women and in people with BMI of greater than 26 kg/m(2), the levels of blood glucose, insulin,”
- Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission (2009, background): “Epidemiologic studies indicate that diabetes is correlated with increased risk of breast and other cancers ( 3 , 4), and we recently defined a transcriptional signature and drug sensitivity profile of cellular transformation linking multiple types of cancer with diabetes and other metabolic diseases”
- Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention (2014, background): “Epidemiologic evidence has demonstrated that diabetes may elevate the risk of cancer such as colorectal cancer [80], liver cancer [81], bladder cancer [82], breast cancer [83], kidney cancer [84], which varies depending on the subsites of specific cancers.”
- Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study (2009, neutral): “28) for breast cancer [3–5].”
- Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality. (2015, background): “esophageal cancer in men (83); breast and endometrial cancer in women (58, 108); and kidney and colorectal cancer in men and women (109, 110) have been reported.”